YM155 inhibits topoisomerase function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

YM155 inhibits topoisomerase function

Published:2017-02 Issue:2 Volume:28 Page:142-152
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Hong Mei,Ren Ming-Qiang,Silva Jeane,Paul Ananya,Wilson W. David,Schroeder Carsten,Weinberger Paul,Janik John,Hao Zhonglin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference44 articles.

1. DNA topoisomerases: structure, function, and mechanism;Champoux;Annual review of biochemistry,2001

2. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I;Streltsov;J Biomol Struct Dyn,2002

3. Cell death induced by topoisomerase-targeted drugs: more questions than answers;Kaufmann;Biochim Biophys Acta,1998

4. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II;Tewey;Science,1984

5. Nonintercalative antitumor drugs interfere with the breakage–reunion reaction of mammalian DNA topoisomerase II;Chen;J Biol Chem,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-related cell death index and its application for hepatocellular carcinoma;npj Precision Oncology;2024-09-08

2. Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling;Cancers;2024-09-05

3. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC;International Journal of Molecular Sciences;2023-12-22

4. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development;Life Sciences;2023-12

5. Senescence‐based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies;MedComm;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3